Defending in a serious case involving two pharmacists alleged to have stolen pharmaceuticals for illicit distribution. The principal issue became the distinction between the branded and generic prices of the drugs.
The pharmaceutical industry was less than keen for these huge price differences to be revealed because of the little-known practice of "brand equalisation" which leads to branded drugs being sold at the lower generic price. Over a series of hearings Selva pressed for disclosure and presented argument which led to the judge ruling that the case should proceed on the substantially lower generic values.